atenolol has been researched along with Obstructive Lung Diseases in 19 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized, placebo-controlled, double-blind crossover investigation in 12 patients with non-asthmatic chronic obstructive lung disease and co-existing stable angina pectoris was done to compare two beta 1-selective adrenoceptor blocking agents, atenolol 100 mg and bisoprolol 20 mg." | 9.06 | Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris. ( Bethge, H; Dorow, P; Tönnesmann, U, 1986) |
| "1 The effects of atenolol (100 mg), a cardioselective beta-adrenoceptor blocking agent, and labetalol (300 mg), a combined alpha- and non-selective beta-adrenoceptor blocking agent given in single doses were examined in a double-blind placebo controlled study in 11 asthmatic patients with hypertension." | 9.05 | Comparison of the effects of single doses of atenolol and labetalol on airways obstruction in patients with hypertension and asthma. ( Beevers, DG; Jackson, SH, 1983) |
| "5." | 6.64 | Clinical evaluation of atenolol in hypertension. ( Aberg, H; Hansson, L; Henningsen, NC; Jameson, S; Karlberg, BE; Westerlund, A, 1976) |
| "To compare efficacy and safety of atenolol, methoprolol and bisoprolol, as the most usable beta-blockers, in patients with isolated systolic arterial hypertension (ISAH) and concomitant diabetes mellitus (DM) and/or chronic obstructive pulmonary disease (COPD)." | 5.10 | [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases]. ( Abakumov, IuE; Batutina, AM; Kukes, VG; Mamaev, VI; Ostroumova, OD; Zykova, AA, 2003) |
| "A randomized, placebo-controlled, double-blind crossover investigation in 12 patients with non-asthmatic chronic obstructive lung disease and co-existing stable angina pectoris was done to compare two beta 1-selective adrenoceptor blocking agents, atenolol 100 mg and bisoprolol 20 mg." | 5.06 | Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris. ( Bethge, H; Dorow, P; Tönnesmann, U, 1986) |
| " This study concerned 21 patients: 8 asthmatics and 13 spastic bronchitics, treated over a period of 4 months in a cross-over, double-blind test by 2 cardio-selective beta-blockers (2 months: betaxolol, 2 months atenolol)." | 5.06 | [Long-term beta adrenergic antagonists in spastic bronchopathies]. ( Blaive, B; Lemoigne, F; Lewest, G; Nahon, F, 1988) |
| "1 The effects of atenolol (100 mg), a cardioselective beta-adrenoceptor blocking agent, and labetalol (300 mg), a combined alpha- and non-selective beta-adrenoceptor blocking agent given in single doses were examined in a double-blind placebo controlled study in 11 asthmatic patients with hypertension." | 5.05 | Comparison of the effects of single doses of atenolol and labetalol on airways obstruction in patients with hypertension and asthma. ( Beevers, DG; Jackson, SH, 1983) |
| "Cardioselectivity of a single oral dose of metoprolol oral osmotic (OROS) (14/190 mg) and atenolol (100 mg) was compared in 12 patients with reversible obstructive airway disease by assessing the dose-response curve to increasing doses of inhaled salbutamol." | 2.67 | Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study. ( Bruni, B; Dottorini, ML; Grassi, V; Lecaillon, JB; Motolese, M; Peccini, F; Sorbini, CA; Tantucci, C, 1990) |
| "Treatment with labetalol, on the other hand, led to an improvement in respiratory function." | 2.66 | Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease. ( Dal Negro, RW; Pomari, C; Trevisan, F; Turco, P; Zoccatelli, O, 1986) |
| "Propranolol was the only drug that significantly increased airways obstruction (FEV1, specific airways resistance)." | 2.65 | Labetalol, beta blockers, and acute deterioration of chronic airway obstruction. ( Adam, WR; Barter, CE; Meagher, EJ, 1982) |
| "5." | 2.64 | Clinical evaluation of atenolol in hypertension. ( Aberg, H; Hansson, L; Henningsen, NC; Jameson, S; Karlberg, BE; Westerlund, A, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (78.95) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kukes, VG | 1 |
| Ostroumova, OD | 1 |
| Mamaev, VI | 1 |
| Batutina, AM | 1 |
| Abakumov, IuE | 1 |
| Zykova, AA | 1 |
| Dolce, E | 1 |
| Misceo, N | 1 |
| Partipilo, N | 1 |
| Pirrelli, A | 1 |
| Adam, WR | 1 |
| Meagher, EJ | 1 |
| Barter, CE | 1 |
| Vankov, T | 1 |
| Khadzhipetrov, N | 1 |
| Georgiev, S | 1 |
| Jackson, SH | 1 |
| Beevers, DG | 1 |
| Molho, M | 1 |
| Lidgy, M | 1 |
| Ezra, D | 1 |
| Rosenthal, T | 1 |
| Beil, M | 1 |
| Ulmer, WT | 1 |
| Hansson, L | 1 |
| Karlberg, BE | 1 |
| Aberg, H | 1 |
| Westerlund, A | 1 |
| Henningsen, NC | 1 |
| Jameson, S | 1 |
| Scott, JS | 1 |
| Berney, CE | 1 |
| Derksen, FJ | 1 |
| Robinson, NE | 1 |
| Fogari, R | 1 |
| Zoppi, A | 1 |
| Tettamanti, F | 1 |
| Poletti, L | 1 |
| Rizzardi, G | 1 |
| Fiocchi, G | 1 |
| Tantucci, C | 1 |
| Bruni, B | 1 |
| Dottorini, ML | 1 |
| Peccini, F | 1 |
| Motolese, M | 1 |
| Lecaillon, JB | 1 |
| Sorbini, CA | 1 |
| Grassi, V | 1 |
| Opie, LH | 1 |
| Schiess, W | 2 |
| Dorow, P | 3 |
| Giorgis, GE | 1 |
| Galietti, F | 1 |
| Miravalle, C | 1 |
| Barberis, S | 1 |
| Massaglia, GM | 1 |
| Onoscuri, E | 1 |
| Dal Negro, RW | 1 |
| Zoccatelli, O | 1 |
| Pomari, C | 1 |
| Trevisan, F | 1 |
| Turco, P | 1 |
| Bethge, H | 1 |
| Tönnesmann, U | 1 |
| Blaive, B | 1 |
| Nahon, F | 1 |
| Lemoigne, F | 1 |
| Lewest, G | 1 |
13 trials available for atenolol and Obstructive Lung Diseases
| Article | Year |
|---|---|
[Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
Topics: Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambula | 2003 |
Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Ethanolamines; Humans; Hypertension; Labetalol; Lung Di | 1982 |
[Use of beta 1-selective beta blockers in patients with obstructive airway diseases].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Female; Heart Rate; Humans; Lung Di | 1983 |
Comparison of the effects of single doses of atenolol and labetalol on airways obstruction in patients with hypertension and asthma.
Topics: Adult; Asthma; Atenolol; Blood Pressure; Ethanolamines; Female; Forced Expiratory Volume; Humans; Hy | 1983 |
[Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease (author's transl)].
Topics: Adult; Aged; Airway Resistance; Atenolol; Blood Pressure; Bronchi; Chronic Disease; Clinical Trials | 1977 |
Clinical evaluation of atenolol in hypertension.
Topics: Antihypertensive Agents; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Lung Diseases, Ob | 1976 |
Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Celiprolol; Forced Expiratory Volume | 1990 |
Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study.
Topics: Adolescent; Adult; Aged; Airway Resistance; Albuterol; Atenolol; Clinical Trials as Topic; Double-Bl | 1990 |
Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Atenolol; Blood Pressure; Dose-Response Relat | 1986 |
Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Atenolol; Clinical Trials as Topic; Dose-Resp | 1986 |
Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Airway Resistance; Atenolol; Chlorthalidone; Drug Therapy, Combination; | 1986 |
Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Angina Pectoris; Atenolol; Bisoprolol; Double | 1986 |
[Long-term beta adrenergic antagonists in spastic bronchopathies].
Topics: Adrenergic beta-Antagonists; Asthma; Atenolol; Betaxolol; Bronchitis; Drug Evaluation; Drug Toleranc | 1988 |
6 other studies available for atenolol and Obstructive Lung Diseases
| Article | Year |
|---|---|
[Cardioselective beta-blocking agents and respiratory function].
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Female; Humans; Hypertension; Lung Diseases, Obstructi | 1980 |
[Use of Falicard and Sectral in patients with COPD and ischemic heart disease].
Topics: Angina Pectoris; Atenolol; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Humans; Lun | 1983 |
[Effect of atenolol on airway resistance in hypertensive patients with chronic obstructive lung disease].
Topics: Airway Resistance; Atenolol; Double-Blind Method; Humans; Hypertension; Lung Diseases, Obstructive; | 1981 |
Beta-adrenergic receptor activity in ponies with recurrent obstructive pulmonary disease.
Topics: Aerosols; Animals; Atenolol; Butoxamine; Histamine; Horse Diseases; Horses; Isoproterenol; Lung Dise | 1991 |
Mechanism of smooth muscle contraction: relevance to safety of beta-adrenergic blockade in hypertensive patients with reversible chronic obstructive airways disease.
Topics: Adrenergic beta-Antagonists; Atenolol; Bronchi; Calcium Channel Blockers; Calmodulin; Celiprolol; Cy | 1986 |
[Possibilities of using cardioselective beta blocking agents in patients with chronic obstructive bronchopneumopathies].
Topics: Acebutolol; Adrenergic beta-Antagonists; Aerosols; Aged; Atenolol; Blood Pressure; Female; Forced Ex | 1986 |